Glen Eagle Advisors’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-300
| Closed | -$5.39K | – | 944 |
|
2021
Q3 | $5.39K | Hold |
300
| – | – | ﹤0.01% | 809 |
|
2021
Q2 | $6.86K | Hold |
300
| – | – | ﹤0.01% | 764 |
|
2021
Q1 | $4.49K | Hold |
300
| – | – | ﹤0.01% | 785 |
|
2020
Q4 | $1.62K | Hold |
300
| – | – | ﹤0.01% | 868 |
|
2020
Q3 | $1.37K | Hold |
300
| – | – | ﹤0.01% | 824 |
|
2020
Q2 | $1.48K | Hold |
300
| – | – | ﹤0.01% | 782 |
|
2020
Q1 | $945 | Hold |
300
| – | – | ﹤0.01% | 754 |
|
2019
Q4 | $777 | Hold |
300
| – | – | ﹤0.01% | 844 |
|
2019
Q3 | $948 | Hold |
300
| – | – | ﹤0.01% | 756 |
|
2019
Q2 | $1.01K | Hold |
300
| – | – | ﹤0.01% | 734 |
|
2019
Q1 | $915 | Buy |
+300
| New | +$915 | ﹤0.01% | 700 |
|